Drug for correction of mitochondrial dysfunction
AssigneeVladislav Nikolaevich LASKAVY
InventorsVladislav Nikolaevich LASKAVY, Mikhail Arkadevich SHURDOV
Life of this patent
Estimating the term…
Loading patent…
AssigneeVladislav Nikolaevich LASKAVY
InventorsVladislav Nikolaevich LASKAVY, Mikhail Arkadevich SHURDOV
Estimating the term…
The invention relates to the field of experimental medicine and concerns the creation of a novel effective agent for correcting mitochondrial dysfunction in laboratory animals. The claimed invention addresses the technical problem of creating an effective and easy-to-use agent for the experimental correction of mitochondrial dysfunction. The technical result consists in increasing mitochondrial membrane potential and increasing neutrophil oxygen-dependent metabolism. This technical result is achieved by using an immunomodulatory agent for intramuscular injection, containing formaldehyde in an amount of 0.076-0.078% in an isotonic solution of sodium chloride at a concentration of 0.85-0.95%, as an agent for increasing mitochondrial membrane potential and increasing neutrophil oxygen-dependent metabolism.
The use of the immunomodulatory drug for intramuscular injection containing the active agent in the form of formic aldehyde in an amount of 0.076-0.078% and an additive in the form of an isotonic solution of sodium chloride for injection of 0.85-0.95% concentration—the rest, as a drug for increasing the membrane mitochondrial potential and increasing the oxygen-dependent metabolism of neutrophils.
Dependencies are inferred from the claim text.